History
For more than 30 years, ETAP-Lab for “Ethologie Appliquée” (Applied Ethology in English) has established itself as a valuable partner in the performance of preclinical studies for pharmaceutical companies, biotech and agro-food industry.
First specialised in rodent behaviour assessment, its co-founders Michaël MESSAOUDI and Pierre BOURGOGNE started the activity of ETAP-Lab in 1991 proposing Psychopharmacology and Neuropharmacology models for pharmaceutical companies.
ETAP-Lab has always sought to be at the cutting edge of in vivo preclinical services. As a matter of fact, one decade before the first European rule about health and nutrition claims, ETAP-Lab expanded its activity to the budding market of nutraceutics, proposing to agro-food industry the entire exigency and the processes used for pharmacological drugs. The project scaled-up with the arrival of Dr Pascale ROZAN as Nutrition-Health Manager (2001).
After this turning point, ETAP-Lab focused its activity on the development of original models of human pathologies with high translational value, useful for both pharmacological compounds and agro-food industries products. ETAP-Lab also enriched its services by incorporating models from 3 new fields under the direction of Dr Jean-François BISSON (2003): Cancerology, Dermatology and regulatory Toxicology.
To complete its activities, ETAP-Lab next developed preclinical models in 2 other fields: Cerebrocardiovascular diseases with the recruitment of Dr Nicolas VIOLLE (2009) and Aging and Neurodegenerative diseases under the supervision of Dr Christophe MULLER (2010).
In 2024, ETAP-Lab has successfully renewed its ISO9001:v2015 certification. This achievement underlines its commitment to providing exemplary preclinical research services. Robust quality management system developed over 10 years ago, backed by ISO9001 certification, ensures quality, reliability and customer satisfaction.
The certificate was granted by OFC until October 1, 2027 for its Quality Management System for consulting, advising and study expertise in the field of in vitro and in vivo preclinical research.
With two decades of experience in preclinical in vivo testing and rodent behavioural analysis, the ETAP-Lab team is able to develop and customize relevant animal models with high translational value that fit to your specific goals, from the proof-of-concept to the early development. ETAP-Lab’s team is listening to your needs to find the best solution for evaluating the potential effects of your products, just contact us !
Ethics
Quality
Respect
Laboratories
Our Research Centers are fully designed and equipped to ensure cutting-edge quality for preclinical studies.
- 2,200m² of dedicated research laboratories incl. 1,000m² for experimental studies
- Our laboratories include an analytical lab, in vitro and in vivo labs
- Our facilities include animal rooms, behavioral test rooms, multiple-surgical workstations, hematology room, chemical preparation room
- Up-to-date equipments including High-Content Imaging System, and access to a rodent PET-scan and an MRI
- ISO9001:v2015 certification for all ETAP-Lab’s preclinical services.
In 2024 we have invested in new facilities for STROK@LLIANCE in 2024 to support preclinical Stroke research in Caen-France!
We can now produce 3 times more neurovascular diseases studies in 700m² of installations, including 400m² of laboratories with modern equipments.
In the near future, ETAP-Lab will integrate larger premises that still need to be built, in Nancy-France! Multiplying by 3 the overall research capacity.